Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb. Miron Y, Miller PE, Hughes C, Indersmitten T, et al. J Allergy Clin Immunol 2022;150:690-700.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miron Y, Miller PE, Hughes C, Indersmitten T, et al. Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb. J Allergy Clin Immunol 2022;150:690-700.
PMID: 35240144